INDOLEAMINE 2,3-DIOXYGENASE INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION
申请人:Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
公开号:US20190040025A1
公开(公告)日:2019-02-07
The present invention relates to an indoleamine 2,3-dioxygenase inhibitor having the structure of formula (I), a preparation method therefor, and an application. The IDO inhibitor is an N′-hydroxyl-N-phenylformamidine derivative, which has a high inhibitory activity on IDO, effectively inhibits IDO activity, and may also be used to inhibit patient immunosuppression. The inhibitor may be widely applied to treat or prevent cancers or tumors, viral infections, depression, neurodegenerative disorders, trauma, age-related cataracts, organ transplant rejection or autoimmune diseases, and has the potential to be developed into a new generation of immunosuppressors.
本发明涉及一种具有式(I)结构的吲哚胺2,3-二氧化酶抑制剂,其制备方法及应用。IDO抑制剂是N'-羟基-N-苯甲酰胺衍生物,对IDO具有高抑制活性,有效抑制IDO活性,也可用于抑制患者的免疫抑制作用。该抑制剂可广泛应用于治疗或预防癌症或肿瘤、病毒感染、抑郁症、神经退行性疾病、创伤、年龄相关性白内障、器官移植排斥或自身免疫疾病,并有潜力发展成为新一代免疫抑制剂。